TY - JOUR
T1 - Correction to
T2 - Validation of the diagnostic criteria for IgG4‑related kidney disease (IgG4‑RKD) 2011, and proposal of a new 2020 version (Clinical and Experimental Nephrology, (2021), 25, 2, (99-109), 10.1007/s10157-020-01993-7)
AU - Saeki, Takako
AU - Kawano, Mitsuhiro
AU - Nagasawa, Tasuku
AU - Ubara, Yoshifumi
AU - Taniguchi, Yoshinori
AU - Yanagita, Motoko
AU - Nishi, Shinichi
AU - Nagata, Michio
AU - Hisano, Satoshi
AU - Yamaguchi, Yutaka
AU - Nomura, Hideki
AU - Saito, Takao
AU - Nakashima, Hitoshi
N1 - Publisher Copyright:
© 2021, Japanese Society of Nephrology.
PY - 2021/4
Y1 - 2021/4
N2 - In the original publication of the article, the sensitivity% of the Plan C-1 value in Table 6 has appeared incorrectly as 90.0. The correct value should be 90.9. The corrected Table 6 is given below. (Table presented.). Plan A: Change the pathology-related item: dense lymphoplasmacytic infiltration with (a) IgG4-positive plasma cells > 10/high power field (HPF) and/or (b) IgG4/IgG-positive plasma cells > 40% to “(a) and (b)” Plan B: Deletion the item “storiform fibrosis” from among histologic findings in the kidney Plan C: Addition the item “imaging or clinical findings compatible with extra-renal organ(s)” as an extra-renal organ(s) item Plan C-1: 1) bilateral lacrimal gland swelling or 2) bilateral submandibular or parotid gland swelling, or 3) imaging findings compatible with type 1 autoimmune pancreatitis, or 4) imaging features of retroperitoneal fibrosis Plan C-2: 1) and 2), or 3), or 4) Plan C-3: 1) or 2), or 3) Plan C-4: 1) and 2), or 3).
AB - In the original publication of the article, the sensitivity% of the Plan C-1 value in Table 6 has appeared incorrectly as 90.0. The correct value should be 90.9. The corrected Table 6 is given below. (Table presented.). Plan A: Change the pathology-related item: dense lymphoplasmacytic infiltration with (a) IgG4-positive plasma cells > 10/high power field (HPF) and/or (b) IgG4/IgG-positive plasma cells > 40% to “(a) and (b)” Plan B: Deletion the item “storiform fibrosis” from among histologic findings in the kidney Plan C: Addition the item “imaging or clinical findings compatible with extra-renal organ(s)” as an extra-renal organ(s) item Plan C-1: 1) bilateral lacrimal gland swelling or 2) bilateral submandibular or parotid gland swelling, or 3) imaging findings compatible with type 1 autoimmune pancreatitis, or 4) imaging features of retroperitoneal fibrosis Plan C-2: 1) and 2), or 3), or 4) Plan C-3: 1) or 2), or 3) Plan C-4: 1) and 2), or 3).
UR - http://www.scopus.com/inward/record.url?scp=85102034743&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85102034743&partnerID=8YFLogxK
U2 - 10.1007/s10157-021-02040-9
DO - 10.1007/s10157-021-02040-9
M3 - Comment/debate
C2 - 33656640
AN - SCOPUS:85102034743
VL - 25
SP - 443
EP - 444
JO - Clinical and Experimental Nephrology
JF - Clinical and Experimental Nephrology
SN - 1342-1751
IS - 4
ER -